Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Baricitinib is effective for severe alopecia areata but has some side effects.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Alitretinoin can effectively treat frontal fibrosing alopecia.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

New medications could improve treatment for severe alopecia areata in Australia.

Adalimumab may cause severe hair loss in some patients.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.